Here is a good read from a post on the Facebook group. I

New Post Public Reply Private Reply Replies (5) Message Board
ekimozzir
Here is a good read from a post on the Facebook group. I thought some may enjoy it... It is just one man's perspective

Our company is expanding rapidly.
Despite this summer's industry wide decline, and our own PPS being lower than the high of the year, we are still up over 1000% for the year.
Based on what it is reasonable to expect from the increased market awareness that our license will cause on arrival, and the range of activity granted by that license, it could be entirely possible to see an increase of another 1000% in the short term.
This valuation is based primarily on the desperate need of the Canadian market for the MMJ of consistent quality that Cen Biotech is ready to produce.
But that is only one segment of what this company endeavors. We are going to be heavily involved in Hemp production, on a Global scale, and the re-introduction of it's many industrial uses, as well as construction, dietary, and environmental.
This in itself will prove to be revenue generator of immense potential.
Those of us who have continued to do our Due Diligence on what the merger with RXNB brings to the cooperate portfolio, have discovered a multitude of websites that indicate many facets of the medical, pharmaceutical, and supplement markets.
Some of these websites are active, and some are merely place holders, possibly representing future forays into new market segments.
Some of these Placeholder sites seem to indicate preparation for the introduction of products that are still being researched by the leading edge medical professionals on our Board of Directors.
Admittedly such speculations on the future potential of the use of placeholder sites won't do anything for our share value in the short term. However it does serve to indicate the cooperate foresightedness to seek out those people who are working in areas that will benefit from access to our product line.
As for what is affecting our PPS currently, the biggest factor is the apparent stagnation of the Licensing process. as much as the wait has been wearing on our collective patience, it is justified by the previous failure in so many early licensees to be able to produce a clean mold free product.
When our company is finally Licensed, it will create the new industry standard, making it considerably harder for other companies to succeed.
Another issue that effects our PPS is the manipulation of the Market Movers who continuing to accumulate by taking advantage of weak traders who are swayed by the negativity generated by paid detractors. (bashers) who use misdirection to create confusion.
One of the avenues of misdirection is the implication of insider selling by our C.E.O. The simple fact of the matter is, the paltry amount that he would be able to sell, based on the 144's, is an amount that would have, by itself, very little effect on the PPS because of the trading volume. What we don't know is, how much of the stated amount, did he sell, and how much of what he sold, did he end up putting right back into the further progress of the company? Based on the amount of activity we have seem from Bill lately, meeting with government officials in both the Ukraine and Tanzania, it is reasonable to assume, that he has invested in more revenue streams to increase the companies global footprint.
This brings us to the subject of Transparency; Seeing all these pictures of Bill with all these foreign dignitaries is probably as transparent as it would be prudent to be at this time. If he was more open with the extant of these negotiations, it might allow other companies to sneak through the cracks and undermine his efforts.
One of his most transparent moves was showing Dr. Sam on the Ukraine trip, which lets us know that the merger is, for all intents and purposes, a done deal.
An announcement on the details of the merger are probably being withheld until after the license announcement, to be effective in improving total valuation at a time of increased market visibility.
In an effort to be transparent as to the direction the company is taking, last week we saw the pictures from the open house in Lakeshore, that included the one with pink lit shelves.
That picture comes from an established and reputable Bio-therapeutics company in Texas, that represents the highest level of technologies available in cGMP manufacturing.
If an essential component of our business model is to use technologies proven by companies of that caliber, then we will have a significant market advantage. We will be able to consistently produce massive quantities of our product in a rigidly controlled environment.
We will succeed because the world needs safe and high quality medicine without dangerous side-effects.
So in conclusion, don't worry about the current share price, it is in no way representative to the intrinsic value of the company. Do not worry about the unintelligent rantings of an insignificant group of uneducated paid bashers.
Trust your own Due Diligence. Recognize all the potential of the FITX family of companies, and of our esteemed Board of Directors. We are part of something big, and it's only going to get bigger!
Hold your imminently very valuable shares tight. you will be very glad you did!

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

HawkEye 360 Expands with Advanced Satellite Launch

Updated Category News Views 4

Another Triumph for Signals Intelligence Launches come and go, but HawkEye 360's recent deployment of Cluster 16 isn't just another tick on their list. This satellite trio is kitted out with tech that propels the firm deeper into the realm of signals intelligence, where every second counts. The Art of Keeping Up with Demand Now, it's no simple feat to manage rocket...

Continue Reading
Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Updated Category News Views 66

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Continue Reading
Understanding New Jersey's Gun Laws Through Legal Eyes

Updated Category News Views 14

Cracking New Jersey's Complex Legal Code You ever try to decode the rulebook judges play by when gun possession and aggravated assault enter the picture in New Jersey? Well, it's as tricky as picking a safe with a wet noodle. Thankfully, a legal eagle named Ed Weinstock sheds some light on this murky terrain. Now, this isn't just some academic exercise—it's a look into...

Continue Reading
PlanetiQ’s GNSS-RO Expansion: New Satellites Launched

Updated Category News Views 5

PlanetiQ Sets New Pace with Satellite Launches Another day, another launch, eh? PlanetiQ is on a roll! The commercial provider of GNSS radio occultation (GNSS-RO) weather data isn't just resting on its laurels. This October alone, the outfit has blasted two new satellites into the great beyond. That's right, partner—they're stacking assets like poker chips. Quick...

Continue Reading
Americas Cardroom Smashes Prize Pools; Bahamas Up Next

Updated Category News Views 27

Ah, poker. Where dreams are won with a flick of the wrist and a well-placed bluff. This week, it was all eyes on Americas Cardroom’s Dual Venom PKOs, and let me tell you, they didn't just meet expectations—they chewed them up and spat them out like yesterday's jam. Two Titans Crowned in Poker Showdown The action wrapped up with a jaw-dropping $6,862,500 prize pool....

Continue Reading
Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 149

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
Divorce Expertise: Obenhaus Adds CDFA Credential

Updated Category News Views 21

Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...

Continue Reading
Anavex Faces Securities Lawsuit: Investor Implications

Updated Category News Views 39

Storm Clouds Over Anavex: What Investors Need to Know If you've got a slice of Anavex Life Sciences Corp. (NASDAQ: AVXL) in your portfolio, the latest chapter of their legal saga feels less like a twist and more like a twist of the knife. These lawsuits often come out of left field for investors, but this one seems like a slow train that’s been gathering steam for a...

Continue Reading
FP Movement Opens Energizing Boutique in Cranston, RI

Updated Category News Views 23

FP Movement Expands with Style in Rhode Island FP Movement is shaking things up in Cranston, Rhode Island, bringing its signature activewear vibe to Garden City Center with a new shop. It’s not just about buying leggings anymore; it’s about diving into a lifestyle that screams energy and community spirit. The store, which spans 1,209 selling-square-feet, opened its...

Continue Reading
Malteurop's Big Bet in China: A Malt Monopoly Move

Updated Category News Views 4

Malteurop’s Ambitious Leap into China Folks, it looks like Malteurop, the malting arm of the French VIVESCIA Group, is digging its French roots deep into Chinese soil with a move that screams strategy. They’ve just scooped up the Chunlei Malting Co. plant in Jiangsu province, which cranks out enough malt to sling two billion liters of beer annually. Yeah, that's quite...

Continue Reading
blog__more"> More News Articles